Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mrinal M Patnaik

Showing results (1-10 of 416) with videos related to

Pageof 42
Sort By:
Lancet (London, England)|December 4, 2023
Telomerase inhibition in haematological neoplasms-are we ready for primetime?Mrinal M Patnaik
Clinical Medicine & Research|July 4, 2009
Inclusion bodies in tick-borne diseases diagnosed in patients from northern WisconsinMrinal M Patnaik
Haematologica|March 3, 2022
How I diagnose and treat chronic myelomonocytic leukemiaMrinal M Patnaik
Leukemia Research|July 31, 2023
Clonal hematopoiesis of indeterminate potential: Overmedicalization or context dependant relevance?Mrinal M Patnaik
Leukemia & Lymphoma|November 23, 2017
The importance of FLT3 mutational analysis in acute myeloid leukemiaMrinal M Patnaik
Future Oncology (London, England)|June 15, 2017
Midostaurin for the treatment of acute myeloid leukemiaMrinal M Patnaik
Best Practice & Research. Clinical Haematology|May 29, 2020
Myelodysplastic/myeloproliferative neoplasms - Justified inclusion as unique biological entitiesMrinal M Patnaik
Best Practice & Research. Clinical Haematology|May 29, 2020
Juvenile myelomonocytic leukemia - A bona fide RASopathy syndromeTerra Lasho, Mrinal M Patnaik
American Journal of Hematology|November 20, 2021
Targeting ineffective hematopoiesis in myelodysplastic syndromesMrinal M Patnaik, Valeria Santini
British Journal of Haematology|November 2, 2025
Chronic myelomonocytic leukaemiaAyalew Tefferi, Mrinal M Patnaik
Pageof 42

Showing results (1-10 of 416) with videos related to

Sort By:
Pageof 42
Lancet (London, England)|December 4, 2023
Telomerase inhibition in haematological neoplasms-are we ready for primetime?Mrinal M Patnaik
Clinical Medicine & Research|July 4, 2009
Inclusion bodies in tick-borne diseases diagnosed in patients from northern WisconsinMrinal M Patnaik
Haematologica|March 3, 2022
How I diagnose and treat chronic myelomonocytic leukemiaMrinal M Patnaik
Leukemia Research|July 31, 2023
Clonal hematopoiesis of indeterminate potential: Overmedicalization or context dependant relevance?Mrinal M Patnaik
Leukemia & Lymphoma|November 23, 2017
The importance of FLT3 mutational analysis in acute myeloid leukemiaMrinal M Patnaik
Future Oncology (London, England)|June 15, 2017
Midostaurin for the treatment of acute myeloid leukemiaMrinal M Patnaik
Best Practice & Research. Clinical Haematology|May 29, 2020
Myelodysplastic/myeloproliferative neoplasms - Justified inclusion as unique biological entitiesMrinal M Patnaik
Best Practice & Research. Clinical Haematology|May 29, 2020
Juvenile myelomonocytic leukemia - A bona fide RASopathy syndromeTerra Lasho, Mrinal M Patnaik
American Journal of Hematology|November 20, 2021
Targeting ineffective hematopoiesis in myelodysplastic syndromesMrinal M Patnaik, Valeria Santini
British Journal of Haematology|November 2, 2025
Chronic myelomonocytic leukaemiaAyalew Tefferi, Mrinal M Patnaik
Pageof 42